Consensus InspireMD, Inc.

Equities

NSPR

US45779A8466

Market Closed - Nasdaq Other stock markets 16:30:01 2024-05-13 EDT			5-day change	1st Jan Change
2.4 ^USD	+7.38%		+13.20%	-14.59%

01:11pm	Earnings Flash (NSPR) INSPIREMD Posts Q1 Revenue $1.5M, vs. Street Est of $1.9M	MT
03-06	Transcript : InspireMD, Inc., Q4 2023 Earnings Call, Mar 06, 2024

Evolution of the average Target Price on InspireMD, Inc.

Price target over the last 5 years

History of analyst recommendation changes

829a088cf977a724.L4eR03ASDIlXcWC9F_PkwgKi-BUI7q-d9TjVDJ84xGY.QsP_mj0hT9sHJC7HWbuWoHDHqkdwpN35kFCHPtVqsktO4sagBntE5CM7Dw~02fc8ada9796c9de937375b989f863d3

Analyst Recommendations on InspireMD, Inc.

Piper Sandler Initiates InspireMD at Overweight With $3 Price Target	23-06-12	MT
Alliance Global Adjusts Price Target on InspireMD to $4.75 From $5.15, Maintains Buy Rating	23-05-17	MT

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

2.4 USD

Average target price

4.5 USD

Spread / Average Target

+87.51%

High Price Target

4.5 USD

Spread / Highest target

+87.51%

Low Price Target

4.5 USD

Spread / Lowest Target

+87.51%

Consensus detail

Consensus revision (last 18 months)

Analysts covering InspireMD, Inc.

Piper Sandler
Alliance Global Partners

Quarterly earnings - Rate of surprise

Company calendar